Gheorghe Doros

7PUBLICATIONS
47CO-AUTHORS
HaematologyClinical chemistry (incl. diagnostics)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersOther biomedical and clinical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 16, 2026
A Case Study of AI-Enabled Software as a Medical Device Cleared by the FDA for Assessing Hemorrhage Risk Index (APPRAISE-HRI) after Trauma.

Andrew Frock, Jeffrey T Robbins, Francisco G Vital-Lopez

|Dec 29, 2025
Detection yield of surrogate tissue biopsies across amyloidosis classes: a large-scale analysis of 4,027 patients.

Natasha J Burke, Lisa M Mendelson, Tracy Joshi

|Mar 18, 2025
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia.

Michael S Conte, Alik Farber, Andrew Barleben

|Aug 05, 2021
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study.

Andrew Staron, Luke Zheng, Gheorghe Doros

|Nov 11, 2020
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities.

Andrew Staron, Lawreen H Connors, Luke Zheng

|Apr 26, 2019
Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis.

Vaishali Sanchorawala, Gheorghe Doros, Anthony C Shelton

Pageof 2

Frequent Collaborators

5 joint publications

Vaishali Sanchorawala

3 joint publications

Andrew Staron

3 joint publications

Luke Zheng

2 joint publications

Lawreen H Connors